LeanLife Health Inc (CSE:LLP) has named natural health product industry veteran Gavin Mah as its new chief operating officer (COO) as the group seeks to take its sales and marketing efforts to the next level.
Mah has been working as an external consultant for the company since the beginning of this year and his new role takes effect from June 1.
"We have been impressed with Mr Mah in the past six months as a real goal getter," said LeanLife's chief executive Stan Lis in a statement.
"Gavin is absolutely determined to generate sales and grow LeanLIfe's business. We are therefore thrilled that he has accepted our offer to work as an officer of the company in the role of COO.
"Mr. Mah has decades of Omega-3 sales, marketing and corporate acquisition experience with major companies in the Natural Health Products industry. This is going to be strategic for LeanLife's future."
LeanLife has developed a patented process to isolate Omega-3 fatty acids from flax (linen) seeds and its shelf-stable extractions are available in oil, emulsion, and powder forms at over 98% purity and can be used as food additives, or as nutraceuticals.
Mah, for seven years, served as director of Canadian Regulatory Affairs at Nature's Way, a leading health company which sells its many nutritional and dietary supplements, including its Omega-3 products, through a variety of channels such as Walmart, noted the company.
He was instrumental in the acquisition by Nature's Way and its parent company Schwabe Pharma (Germany) of Ascenta Health, the leading Omega-3 fish oil manufacturer.
As well as experience working with Health Canada, he also worked with and sold Omega-3 products for both Omega Nutrition and Barleans Oils, two of the largest flax oil companies in the Pacific Northwest.
As president and partner of Biomed International Products Corp, Mah also oversees the manufacturing and global distribution of natural medicines to health practitioners.
Separately, Leanlife said it had issued over 7.8 million shares at C$0.05 each and 2.1 million warrants at C$0.075 each with the warrants expiring on June 2, 2025.
This was to settle debt of C$584,375 on the company's books. The firm also issued 750,000 shares at C$0.05 per share as payment for services.
Contact the author at firstname.lastname@example.org